LifeMD (NASDAQ:LFMD) Updates Q1 2021 Earnings Guidance

Share on StockTwits

LifeMD (NASDAQ:LFMD) updated its first quarter 2021 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of – for the period. The company issued revenue guidance of $18.22 million-$18.22 million, compared to the consensus revenue estimate of $17.01 million.

Separately, Zacks Investment Research lowered shares of LifeMD from a hold rating to a sell rating in a report on Wednesday, April 7th.

Shares of LFMD traded down $0.62 during mid-day trading on Tuesday, reaching $8.80. The company had a trading volume of 23,701 shares, compared to its average volume of 1,174,606. The company’s fifty day simple moving average is $14.45. LifeMD has a fifty-two week low of $1.25 and a fifty-two week high of $33.02.

LifeMD (NASDAQ:LFMD) last announced its quarterly earnings results on Sunday, March 28th. The company reported ($2.56) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.27) by ($2.29). The business had revenue of $12.89 million for the quarter, compared to the consensus estimate of $13.62 million.

In other LifeMD news, COO Brad Michael Roberts bought 5,000 shares of LifeMD stock in a transaction that occurred on Thursday, February 25th. The shares were acquired at an average price of $20.50 per share, for a total transaction of $102,500.00.

About LifeMD

LifeMD, Inc operates as an online direct-to-patient marketing and telemedicine company with a portfolio of health and wellness brands in the United States. It offers ShapiroMD, a medical device for male and female hair loss; RexMD, a men's telehealth brand offering virtual medical treatment from licensed providers for a variety of men's health needs; Nava MD, a female-oriented tele-dermatology and skincare brand that will offer virtual medical treatment from dermatologists and other providers; and iNR Wellness MD, a supplement for immune and digestive support.

Featured Story: Intrinsic Value

Receive News & Ratings for LifeMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeMD and related companies with's FREE daily email newsletter.